Pancreatic Cancer Screening

Screening is recommended for anyone with a high risk of developing pancreatic cancer. Annual screening helps us catch cancer early. Screening also provides the best opportunity for treatment and survival in case we detect a tumor. We analyze your health history and use genetic testing to determine your risk level.

We recommend screening for anyone in these high-risk groups:

• Age 40 or older (in some situations at an earlier age) with one or more first-degree relatives (a parent, sibling or child) with pancreatic cancer
• Positive genetic markers from genetic testing, including BRCA1 and BRCA2 genes (the genes associated with breast cancer), CDKN2A, PRSS1, SPINK1, STK11, TP53, ATM and PALB2.

Your risk increases if more family members are affected. The more family members (on one side of the family) diagnosed with pancreatic cancer, the higher your risk—even if a known genetic mutation is not found.

The Cedars-Sinai PanScan program includes specialists in gastrointestinal disease, oncology, pancreatic surgery, genetic counseling and imaging. Our comprehensive, team-based approach to care includes screening, evaluation and treatment of pancreatic cancer. If you're diagnosed with pancreatic cancer or we detect pancreatic lesions, you receive treatment from a dedicated team of physicians and surgeons with expertise in pancreatic cancer.